#Healthbreakthroughs

In a landmark recognition of their transformative work on multiple sclerosis (MS), Dr. Alberto Ascherio from Harvard University and Dr. Stephen Hauser from the University of California, San Francisco, have been awarded the prestigious Breakthrough Prize in Life Sciences, sharing a $3 million prize. This prize is notable for its size, significantly exceeding that of a Nobel Prize monetary award, and highlights research that has fundamentally redefined our understanding of MS, a neurodegenerative condition affecting millions globally.

A landmark Breakthrough Prize in Life Sciences has recognized two leaders in multiple sclerosis (MS) research. Dr. Alberto Ascherio of Harvard University and Dr. Stephen Hauser of UCSF share a $3 million award for work that reshapes how we understand and treat MS, a neurodegenerative disease affecting millions worldwide.

Ascherio’s work highlights Epstein-Barr virus (EBV) as a major risk factor for MS. In a rigorous 20-year study, he showed that EBV infection increases the risk of developing MS by about 32 times. This positions EBV as a leading known cause of MS and has spurred efforts to develop vaccines that might prevent the disease by targeting the virus. For Thai readers, this underscores the global importance of infectious triggers in chronic diseases and the potential for preventive strategies.